Corporate news

Organic Group revenue growth of 7.5 %, and 7.1 % in core business Solutions for biotech drugs and high-value solutions continue to drive revenues…

Duesseldorf, June 9, 2021 - The virtual Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share. “All…

Organic revenue growth of 3.1 % in core business Strong development in High Value Solutions: Focus on Biological Solutions pays off Adjusted…

Düsseldorf, March 31, 2021. Ambitious targets will direct Gerresheimer's sustainability strategy in the coming years. Among other things, the company…

Düsseldorf, March 1, 2021. The new corporate design visualizes Gerresheimer’s strategic focus on profitable and sustainable growth, innovation,…

Transformation in full swing: Continuous focus on growth delivers first positive results Fourth-quarter Group revenues rise to 403m Euro: 7.3 %…

Duesseldorf, February 18, 2021 – At its meeting yesterday, the Supervisory Board of Gerresheimer AG extended the contract with CEO Dietmar Siemssen…

Transformation into a growth value as innovation leader and solution provider Gerresheimer presents strategy process formula G as an engine towards…

Third quarter on schedule Group revenues EUR 349m; 2.1% organic revenue growth in core business Adjusted EBITDA increases by 4.1% to EUR 75m S…